Internal Medicine, Pulmonary Disease · Rochester, MN
NPI
1144290305
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
200 1st St SW
Rochester, MN, 55905
Phone (507) 284-2511
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
1,303 services
Medicare patients, 2024
507
Average age 73
Drug cost, 2024
$1.7M
4,136 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hamid Rehman was code 94729 (pulmonary function testing), 251 times for 246 patients. In total Hamid Rehman billed 1,303 services in 21 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94729 Pulmonary Function Testing | Facility | 251 | 246 | $6.49 | $1,630 |
| 94060 Pulmonary Function Testing | Facility | 217 | 215 | $7.63 | $1,657 |
| 94726 Pulmonary Function Testing | Facility | 202 | 200 | $8.83 | $1,783 |
| 99214 Office E&M - Established | Office | 116 | 97 | $71.93 | $8,344 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 94 | 89 | $12.91 | $1,214 |
| 94010 Pulmonary Function Testing | Facility | 63 | 62 | $5.99 | $377 |
| 99214 Office E&M - Established | Facility | 58 | 51 | $71.85 | $4,167 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 50 | 47 | $13.31 | $666 |
| 99204 Office E&M - New | Office | 46 | 46 | $99.58 | $4,581 |
| 99213 Office E&M - Established | Office | 27 | 26 | $51.66 | $1,395 |
| 99213 Office E&M - Established | Facility | 27 | 27 | $45.41 | $1,226 |
| 99204 Office E&M - New | Facility | 25 | 25 | $95.96 | $2,399 |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 22 | 22 | $25.38 | $558 |
| 99406 Behavioral Health Services | Office | 20 | 20 | $11.79 | $236 |
| 94070 Pulmonary Function Testing | Facility | 15 | 15 | $21.60 | $324 |
By year: 2022 $41K for 1,240 services; 2023 $42K for 1,339 services; 2024 $33K for 1,303 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hamid Rehman prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 727 prescriptions and refills. In total Hamid Rehman wrote 4,136 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 727 | 907 | 123 | $568K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 598 | 811 | 207 | $26K |
| Ventolin Hfa Albuterol Sulfate | 295 | 396 | 109 | $26K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 291 | 389 | 58 | $46K |
| Breo Ellipta Fluticasone/Vilanterol | 261 | 351 | 47 | $136K |
| Montelukast Sodium Generic | 235 | 604 | 72 | $2,804 |
| Spiriva Respimat Tiotropium Bromide | 229 | 323 | 59 | $164K |
| Incruse Ellipta Umeclidinium Bromide | 199 | 257 | 37 | $88K |
| Prednisone Generic | 147 | 179 | 85 | $470 |
| Azithromycin Generic | 144 | 196 | 77 | $1,463 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 119 | 171 | 23 | $82K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 93 | 125 | 20 | $57K |
| Spiriva Handihaler Tiotropium Bromide | 80 | 116 | 15 | $58K |
| Dulera Mometasone/Formoterol | 73 | 113 | 18 | $38K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 66 | 90 | 19 | $19K |
Brand drugs: 2,890 claims; generic drugs: 1,246 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Hamid Rehman were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.